Journal
JOURNAL OF VIROLOGY
Volume 74, Issue 16, Pages 7651-7655Publisher
AMER SOC MICROBIOLOGY
DOI: 10.1128/JVI.74.16.7651-7655.2000
Keywords
-
Categories
Ask authors/readers for more resources
A problem associated with the use of vaccinia virus recombinants as vaccines is the existence of a large human population with preexisting immunity to the vector. Here we showed that after a booster with attenuated recombinant modified vaccinia virus Ankara (rMVA), higher humoral and cellular immune responses to foreign antigens (human immunodeficiency virus type 1 Env and beta-galactosidase) were found in mice preimmunized with rMVA than in mice primed with the virulent Western Reserve strain and boosted with rMVA. This enhancement correlated with higher levels of expression of foreign antigens after the booster.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available